P.A.W. Capital’s Cognition Therapeutics CGTX Stock Holding History

P.A.W. Capital’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$190K	–	30
2022 Q3	$190K	Sell	100,000 -35,000	-26%	-$72.9K	0.28%	55
2022 Q2	$285K	Buy	135,000 +15,000	+13%	+$38.8K	0.41%	53
2022 Q1	$330K	Buy	120,000 +20,000	+20%	+$77.1K	0.34%	58
2021 Q4	$632K	Buy	+100,000	New	+$975K	0.58%	57

Other funds holding CGTX

AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Carlson Capital Dallas, Texas $253M AUM 27.64% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Voss Capital Houston, Texas $1.75B AUM 1.03% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return